Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score.
about
Systematic Review of the Relationship between Acute and Late Gastrointestinal Toxicity after Radiotherapy for Prostate CancerChronic radiation proctitis: tricks to prevent and treatNovel drugs to ameliorate gastrointestinal normal tissue radiation toxicity in clinical practice: what is emerging from the laboratory?Endoscopic and non-endoscopic approaches for the management of radiation-induced rectal bleedingStereotactic body radiotherapy for organ-confined prostate cancer.Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study.Radiation protection of the gastrointestinal tract and growth inhibition of prostate cancer xenografts by a single compound.Dosimetric analysis of radiation-induced gastric bleedingGastrointestinal radiation injury: prevention and treatment.Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer.Assessment of Radiation Induced Therapeutic Effect and Cytotoxicity in Cancer Patients Based on Transcriptomic Profiling.Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design.Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study.The efficacy of the combination therapy with oral and topical mesalazine for patients with the first episode of radiation proctitis.Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer.Stereotactic body radiotherapy as treatment for organ confined low- and intermediate-risk prostate carcinoma, a 7-year study.Effect of a prostaglandin--given rectally for prevention of radiation-induced acute proctitis--on late rectal toxicity. Results of a phase III randomized, placebo-controlled, double-blind study.Stereotactic body radiotherapy as boost for organ-confined prostate cancer.
P2860
Q26772255-7053EEA1-69CC-4783-A5C4-1F71515570AEQ26801205-8EB9A9F2-9F09-4F1D-A286-9DE824425839Q26823881-B854B29C-7F73-4650-9A6E-1EB6CE4CC285Q28076526-378AB28C-151D-411D-88CD-B266BD8E5969Q33528163-9A4946D2-C253-45A8-A96B-3D0CAA9FB748Q34413524-92996B17-2440-452F-9ED2-ED7AE56A2B3CQ34646655-7DD60AB7-AB73-46CC-B36E-A36FBBA8C0D6Q36177088-60A7FA4B-3C48-450C-902A-615EBD44ACFDQ36541213-E6A59FBA-4210-4D9A-8C9B-69E244F52A96Q36604355-8CFCCF8F-C52F-423F-A113-82A6E6A0F523Q36667200-8D1785B7-CC08-413A-A09B-7C24F53CB51DQ37110245-7E4802D6-BAB6-48C1-9D47-502BB7671E99Q37673453-E04C5FC9-EDDE-41D2-9183-F36AF8F42733Q38476635-50F3251E-7191-4A7D-B026-73B12939C888Q41833334-5030C89B-96FD-49DC-A1DA-A19FFBECB7BFQ41878672-C08EDA0D-D4BC-4B36-A3F6-BEF4AA0BFE46Q43276195-463DD9C4-65F7-4141-8460-1AD44F2A0944Q48764169-9A80A405-41DB-42BD-A7AA-8BCAC007551A
P2860
Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Intrarectal amifostine during ...... f Life measured by EPIC score.
@ast
Intrarectal amifostine during ...... f Life measured by EPIC score.
@en
type
label
Intrarectal amifostine during ...... f Life measured by EPIC score.
@ast
Intrarectal amifostine during ...... f Life measured by EPIC score.
@en
prefLabel
Intrarectal amifostine during ...... f Life measured by EPIC score.
@ast
Intrarectal amifostine during ...... f Life measured by EPIC score.
@en
P2093
P2860
P1476
Intrarectal amifostine during ...... f Life measured by EPIC score.
@en
P2093
Anurag K Singh
Benjamin P Soule
C Norman Coleman
Cynthia Ménard
Denise Godette
Kevin Camphausen
Linda C Sciuto
Nancy S Crouse
Nicole L Simone
Paul S Albert
P2860
P356
10.1016/J.IJROBP.2007.05.057
P407
P577
2007-09-12T00:00:00Z